Biblio
Regulatory T cells suppress myeloma-specific immunity during autologous stem cell mobilization and transplantation. Blood. 2024.
Pegylated interferon-2α invokes graft-versus-leukemia effects in patients relapsing after allogeneic stem cell transplantation. Blood Adv. 2019;3(20):3013-3019.
MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota. Immunity. 2019.
Intestinal microbiota controls graft-versus-host disease independent of donor-host genetic disparity. Immunity. 2023.
Bone marrow transplantation generates T cell-dependent control of myeloma in mice. J Clin Invest. 2018.